Postpartum hemorrhage remains a major obstetric emergency and one of the most important contributors to maternal morbidity and mortality worldwide. Effective management depends on early recognition, systematic evaluation, and rapid implementation of evidence-based therapeutic strategies. A structured clinical approach facilitates identification of the underlying cause and supports timely intervention to prevent progression to severe hypovolemia and organ dysfunction. Risk assessment should begin during the antenatal period, as several maternal and obstetric conditions increase the likelihood of hemorrhagic complications. Intrapartum factors may further elevate risk, making continuous clinical vigilance essential throughout labor and delivery. Preventive measures, including appropriate management of the third stage of labor and prophylactic uterotonic therapy, represent key strategies for reducing the incidence and severity of hemorrhage. Early diagnosis relies on objective assessment of blood loss, continuous hemodynamic monitoring, and the use of structured clinical indicators that help identify deterioration at an early stage. Once hemorrhage is suspected, management requires immediate activation of institutional protocols, rapid hemodynamic stabilization, and a coordinated multidisciplinary response. Therapeutic interventions typically follow a stepwise escalation beginning with pharmacologic uterotonic agents and antifibrinolytic therapy, followed by mechanical measures and, when necessary, surgical procedures to control bleeding. Integration of standardized protocols, goal-directed transfusion strategies, and team-based management is essential to improve outcomes and reduce the burden of severe maternal complications associated with postpartum hemorrhage.
Gómez et al. (Wed,) studied this question.